Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent Drug-Induced Liver Injury

NCT03266146 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT03266146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03266146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent Drug-Induced Liver Injury
Lead sponsor
Beijing 302 Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
September 2, 2017
Completion date
January 31, 2023
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug-induced liver injury,chronic